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Abstract
Objective: This study investigated the factors related to the ratio of the venoarterial carbon
dioxide tension difference [P(v-a)CO2] to the arteriovenous oxygen content difference [C(a-v)O2]
(hereafter termed “Ratio”).
Methods: We retrospectively studied 1294 pairs of arterial and central venous blood gas
measurements in 352 critically ill patients. A high Ratio was defined as> 1.68 based on published
literature. Measurements were divided into four groups: Group I [P(v-a)CO2 6 mmHg/central
venous oxygen saturation (ScvO2)< 70%], Group II [P(v-a)CO2 6 mmHg/ScvO2 70%], Group
III [P(v-a)CO2> 6 mmHg/ScvO2 70%], and Group IV [P(v-a)CO2> 6 mmHg/ScvO2< 70%].
Results: The Ratio’s strongest correlation was with P(v-a)CO2 when compared with ScvO2 and
hemoglobin in all data. The P(v-a)CO2 and ScvO2 were significantly higher and the hemoglobin
and arterial oxygen saturation were significantly lower in the high Ratio measurements (>1.68)
than low Ratio measurements (1.68). The P(v-a)CO2 was best for predicting a high Ratio.
A P(v-a)CO2 threshold of 7 mmHg was associated with a sensitivity of 41.77% and specificity
of 90.62% for predicting a high Ratio.
Conclusions: A high P(v-a)CO2 is the most relevant contributor to a high Ratio among all
related factors in critically ill patients.
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Introduction
The concept of an existing relationship
between oxygen delivery (DO2) and oxygen
consumption (VO2) has been the cornerstone
of shock, and determining DO2/VO2 depen-
dence is a key issue in shock resuscitation.1,2
The ratio of the venoarterial carbon dioxide
tension difference [P(v-a)CO2] to the arterio-
venous oxygen content difference [C(a-v)O2]
[i.e., the P(v-a)CO2/C(a-v)O2 ratio] has gar-
nered much attention as a new marker that
reflects the relationship between DO2 and
VO2. The ratio between VO2 and global
carbon dioxide production (VCO2) is lower
in aerobic than anaerobic metabolism. First,
a decrease in VO2 accompanies a decrease in
aerobically generated carbon dioxide in
terms of tissue hypoxia. In a hypoxic cellular
environment, however, anaerobic carbon
dioxide generation increases as hydrogen
ions generated by anaerobic sources of
energy are buffered by bicarbonate.3
Hence, the ratio between VCO2 and VO2
becomes mismatched, and the amount of
VCO2 generation becomes greater than the
amount of VO2. Consequently, a rise in the
respiratory quotient (VCO2/VO2 ratio)
reflects the presence of global anaerobic
metabolism.4
Many studies have shown that the P(v-a)
CO2/C(a-v)O2 ratio reflects the lactate level,
lactate evolution, and lactate clearance
and is associated with prognosis.5–12
Furthermore, a high C(v-a)CO2/C(a-v)O2
ratio is an independent risk factor for mor-
tality in critically ill patients.8,10 A P(v-a)
CO2/C(a-v)O2 ratio cutoff of 1.68 is a
better predictor of a 15% increase in
VO2 induced by an acute increase in DO2
when compared with lactate and central
venous oxygen saturation (ScvO2).
11,12
The P(v-a)CO2/C(a-v)O2 ratio is calcu-
lated from several parameters based on a
known formula that mainly involves
ScvO2, hemoglobin (Hb), arterial oxygen
saturation (SaO2), and P(v-a)CO2.
13
A theoretical mathematical relationship
exists among these parameters. However,
calculation of the P(v-a)CO2/C(a-v)O2
ratio may involve various combinations of
relevant parameters depending on the clin-
ical situation, which could cause a compli-
cated inter-relationship between the P(v-a)
CO2/C(a-v)O2 ratio and these related
parameters. Therefore, a simple and rapid
method for identification of a high P(v-a)
CO2/C(a-v)O2 ratio would be of substantial
benefit, and the factors contributing to a
high P(v-a)CO2/C(a-v)O2 ratio are worthy
of consideration in the clinical setting.
To our knowledge, the dependency of
the P(v-a)CO2/C(a-v)O2 ratio on ScvO2
and P(v-a)CO2 has not been sufficiently
explored in clinical practice. The present
study was performed to determine the rela-
tionships of ScvO2, Hb, SaO2, and P(v-a)
CO2 with the P(v-a)CO2/C(a-v)O2 ratio;
define the corresponding factors that con-
tribute to a high P(v-a)CO2/C(a-v)O2 ratio
(>1.68) according to the published litera-
ture in critically ill patients;9 and investigate
the behavior of the P(v-a)CO2/C(a-v)O2
ratio in given settings based on specific
cutoff values of P(v-a)CO2 (6 mmHg) and
ScvO2 (70%) for tissue perfusion according
to the published literature.14–16
Patients and methods
Patients and data
The Institutional Research and Ethics
Committee of the Peking Union Medical
College Hospital approved this study.
Because this retrospective study involved
only the collection of clinical data, the
Institutional Research and Ethics Committee
waived the need to obtain consent.
The simultaneous arterial and central
venous blood gas measurements that were
obtained from critically ill patients during
their first week of intensive care unit admis-
sion from July 2013 to December 2014 were
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retrospectively reviewed. The blood gas
analysis data were stored in an electrical
information system in our department. The
attending intensivists decided on the place-
ment of arterial and central venous catheters
according to the severity of the patient’s con-
dition. The P(v-a)CO2/C(a-v)O2 ratio has
been considered a relevant marker of
global anaerobic metabolism, and calcula-
tion of the P(v-a)CO2/C(a-v)O2 ratio was
suggested during resuscitation in
our department.
Standard measurement of the P(v-a)CO2/
C(a-v)O2 ratio involves the following two
steps. First, a central venous catheter is
inserted via the jugular or subclavian vein,
and placement of the central venous catheter
in the superior vena cava is confirmed by
chest radiography. Second, arterial and cen-
tral venous blood gas samples are anaerobi-
cally collected in 3-mL heparinized syringes,
which are analyzed using a bedside blood gas
machine (GEM Premier 3000, model 5700;
Instrumentation Laboratory, Bedford, MA,
USA or ABL90; Radiometer, Copenhagen,
Denmark). The same blood gas machine
was used to measure both the arterial and
central venous blood gas.
Study definitions
Pairs of arterial and central venous blood
samples were used determine the following
variables: arterial oxygen tension (PaO2),
arterial carbon dioxide tension (PaCO2),
central venous oxygen tension (PvO2), cen-
tral venous carbon dioxide tension
(PvCO2), SaO2, and ScvO2. The Hb and
lactate concentrations were measured from
the arterial blood. The arterial oxygen con-
tent (CaO2), central venous oxygen content
(CvO2), C(a-v)O2, P(v-a)CO2, P(v-a)CO2/
C(a-v)O2 ratio, and oxygen extraction per-
centage (EO2) were defined as follows:
• CaO2¼ (1.34SaO2Hb)þ
(0.0031PaO2)
• CvO2¼ (1.34 ScvO2Hb)þ
(0.0031PvO2)
• C(a-v)O2¼CaO2 –CvO2
• P(v-a)CO2¼PvCO2 –PaCO2
• P(v-a)CO2/C(a-v)O2 ratio¼ (PvCO2 –
PaCO2)/(CaO2 –CvO2)
• EO2¼ (SaO2 – SvO2)/SaO2
Moreover, a low and high P(v-a)CO2/
C(a-v)O2 ratio was defined as 1.68
and> 1.68, respectively; a low and high P
(v-a)CO2 was defined as 6 and> 6
mmHg, respectively; and a low and high
ScvO2 was defined as< 70% and 70%,
respectively.
Statistical analysis
Descriptive statistics for continuous varia-
bles were presented as mean standard
deviation when the variables were normally
distributed and as median and interquartile
range (25%–75%) when the variables had a
skewed distribution. The Mann–Whitney
test was used to compare continuous varia-
bles between the groups, and the chi-
squared test and Fisher’s exact test were
used to compare categorical variables.
Comparison of two continuous variables
was performed using Spearman’s correla-
tion. The areas under the receiver operating
characteristic (ROC) curves were compared
using the Hanley–McNeil test.17 The statis-
tical analysis was performed using SPSS
13.0 (SPSS Inc., Chicago, IL, USA) and
MedCalc 11.4.3.0 (MedCalc Software
bvba, Ostend, Belgium). All statistical
tests were two-sided, and a P-value
of< 0.05 was considered statistical-
ly significant.
Results
In total, 1294 pairs of simultaneous arterial
and central venous blood gas measurements
in 352 patients were retrospectively selected
for analysis (mean age, 59 years; range,
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18–91 years; female, n¼ 163; male,
n¼ 189). The study population comprised
96 postoperative patients, 236 patients
with sepsis, and 20 patients with other dis-
eases. The flow diagram in Figure 1 shows
the data analysis of all the measurements.
Correlation between relevant parameters
and P(v-a)CO2/C(a-v)O2 ratio in all
measurements
The distribution of all data reflecting the
P(v-a)CO2/C(a-v)O2 ratio measurements
was skewed (median, 1.45; interquartile
range, 0.93). There was a significant and
strong correlation between P(v-a)CO2 and
P(v-a)CO2/C(a-v)O2 (r¼ 0.692, P< 0.0001)
among the 1294 sets of measurements. Both
the ScvO2 (r¼ 0.104, P< 0.0001) and Hb
(r¼0.159, P< 0.0001) were significantly
correlated with P(v-a)CO2/C(a-v)O2, but
these relationships were weak. However,
P(v-a)CO2/C(a-v)O2, P(v-a)CO2, and ScvO2
were not significantly associated with the
arterial lactate level.
Difference between high and low P(v-a)
CO2/C(a-v)O2 measurements
Thirty-six percent (462/1294) of the meas-
urements had a high P(v-a)CO2/C(a-v)O2
ratio (>1.68). There was a significantly
higher P(v-a)CO2 (P< 0.0001), lower Hb
(P <0.0001), higher ScvO2, (P< 0.0001),
and lower SaO2 (P¼ 0.045) among the high
than low P(v-a)CO2/C(a-v)O2 ratio measure-
ments (Figure 2(a)–(d)). However, there was
no significant difference in lactate (2.7 2.8
vs. 2.7 3.3) between the low and high
P(v-a)CO2/C(a-v)O2 ratio measurements.
The P(v-a)CO2 (area under ROC curve,
0.793) was the best predictor of a high ratio
(>1.68) and was significantly better than
ScvO2 (area under ROC curve, 0.62) and
Hb (area under ROC curve, 0.606)
(Figure 3). The areas under the curve of
the related variables used to predict a high
ratio are shown in Table 1. A P(v-a)CO2
threshold of 7 mmHg was associated with
a sensitivity of 41.77% and a specificity of
90.62% for predicting a high P(v-a)CO2/
C(a-v)O2 ratio (>1.68).
Figure 1. Flow diagram.
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P(v-a)CO2/C(a-v)O2 in different groups
based on ScvO2 (70%) and P(v-a)CO2
(6 mmHg)
Based on the cutoffs of ScvO2 (70%) and
P(v-a)CO2 (6 mmHg), we assigned all meas-
urements to four categories: Group I
[P(v-a)CO2 6 mmHg and ScvO2< 70%],
Group II [P(v-a)CO2 6 mmHg and
ScvO2 70%], Group III [P(v-a)CO2> 6
mmHg and ScvO2 70%], and Group IV
[P(v-a)CO2> 6 mmHg and ScvO2< 70%].
The characteristics of the P(v-a)CO2/C(a-
v)O2 ratio in the different groups are
shown in Table 2. Group I (n¼ 136) had
the lowest P(v-a)CO2/C(a-v)O2 ratio (1.00
 0.46), and Group III (n¼ 209) had the
highest P(v-a)CO2/C(a-v)O2 ratio [2.32
(1.9–3.4)]. Moreover, the lowest percentage
of a high P(v-a)CO2/C(a-v)O2 ratio (>1.68)
was present in Group I [5.8% (8/136)], and
the highest percentage was present in
Group III [84% (176/209)] (Figure 4).
Group I had a significantly higher lactate
level and lower Hb and SaO2 than the
other groups (P< 0.05), and Groups I and
IV had a significantly higher EO2 than the
other groups (Figure 5).
Figure 2. Difference in (a) hemoglobin, (b) P(v-a)CO2, (c) ScvO2, and (d) SaO2 between high and low
P(v-a)CO2/C(a-v)O2 ratio measurements. *P <0.05. P(v-a)CO2, venoarterial carbon dioxide tension
difference; ScvO2, central venous oxygen saturation; SaO2, arterial oxygen saturation; C(a-v)O2,
arteriovenous oxygen content difference.
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Discussion
This is the largest clinical study to date eval-
uating the correlation of ScvO2 and P(v-a)
CO2 with the P(v-a)CO2/C(a-v)O2 ratio in
critically ill patients. The most important
finding of the present study is that the rela-
tionships of ScvO2 and P(v-a)CO2 with the
P(v-a)CO2/C(a-v)O2 ratio were validated
and that the characteristics of the P(v-a)
CO2/C(a-v)O2 ratio were described in the
real-world setting. These data are
meaningful for interpretation of this ratio
in clinical practice.
Factors contributing to a high P(v-a)CO2/
C(a-v)O2 ratio (>1.68)
In the present study, P(v-a)CO2/C(a-v)O2
showed a significantly stronger relationship
with P(v-a)CO2 than ScvO2, Hb, and SaO2.
Importantly, a high P(v-a)CO2 is the most
relevant factor contributing to the high
P(v-a)CO2/C(a-v)O2 ratio among these
Figure 3. Receiving operating characteristic curves showing the ability of ScvO2, P(v-a)CO2, and hemo-
globin to predict a high P(v-a)CO2/C(a-v)O2 ratio of >1.68. ScvO2, central venous oxygen saturation; P(v-a)
CO2, venoarterial carbon dioxide tension difference; C(a-v)O2, arteriovenous oxygen content difference.
Table 1. Comparison of AUCs for predicting a high P(v-a)CO2/C(a-v)O2 ratio (>1.68) in all measurements.
Parameters AUC 95% CI Cutoff value Sensitivity (%) Specificity (%)
Hemoglobin 0.606 0.579–0.633 9.7 g/dL 53.70 64.30
P(v-a)CO2 0.793* 0.769–0.814 7 mmHg 41.77 90.62
ScvO2 0.620 0.468–0.762 79.6% 47.60 69.80
SaO2 0.557 0.525–0.588 99% 42.90 69.20
AUC, area under the receiver operating characteristic curve; P(v-a)CO2, venoarterial carbon dioxide tension difference;
PaO2, arterial oxygen tension; ScvO2, central venous oxygen saturation; SaO2, arterial oxygen saturation; CI, confidence
interval. *P <0.05 for comparison of P(v-a)CO2.
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related parameters. Therefore, the first pri-
ority might be to address the high P(v-a)
CO2 level to restore the P(v-a)CO2/C(a-v)
O2 ratio in critically ill patients. It could
be argued that the variations in these
parameters would impact the relationship
between the included parameters and the
P(v-a)CO2/C(a-v)O2 ratio. Additionally,
both the P(v-a)CO2 and ScvO2 measure-
ments had an abnormal distribution, and
Figure 4. Percentages of a high P(v-a)CO2/C(a-v)O2 ratio (>1.68) in different groups based on the cutoffs
of ScvO2 (70%) and P(v-a)CO2 (6 mmHg). *P <0.05. P(v-a)CO2, venoarterial carbon dioxide tension dif-
ference; C(a-v)O2, arteriovenous oxygen content difference; ScvO2, central venous oxygen saturation.
Table 2. Related parameters in the different groups according to cutoffs of ScvO2 (70%) and P(v-a)CO2
(6 mmHg).
Parameters
Group I
P(v-a)CO2 6 mmHg
and ScvO2< 70%
(n¼ 136)
Group II
P(v-a)CO2 6 mmHg
and ScvO2 70%
(n¼ 751)
Group III
P(v-a)CO2> 6 mmHg
and ScvO2 70%
(n¼ 209)
Group IV
P(v-a)CO2> 6 mmHg
and ScvO2< 70%
(n¼ 198)
ScvO2, % 66 (61–67) 80 (76–84)
a 78 6a 61 (54–67)b,c
P(v-a)CO2, mmHg 4 (2–5) 3.9 (2–5) 8 (7–9.6)
a,b 8 (7–10)a,b
Ratio index 1.00 0.46 1.26 (0.87–1.7)a,c 2.32 (1.9–3.4)a,b 1.6 (1.4–1.9)a,c
Incidence of a
high ratio
8 (5.8) 195 (25.9)a,c 176 (84.0)a 83 (42.0)a,c
Hemoglobin, g/dL 9.9 2.2 10 (8.8–11.6)a 11.1 2.5a 11 2.8a
Lactate, mmol/L 5 (3–6) 1.7 (1.1–2.8)a 1.7 (1.1–2.8)a 2.3 (1.3–4.2)a
SaO2, % 97 (93–99) 99 (97–100)
a 99 (98–100)a 98 (95–100)a
EO2, % 34 0.08 22 0.08a,c 21 0.06a,c 39 0.09a
Data are presented as median (interquartile range), mean standard deviation, or n (%).
ScvO2, central venous oxygen saturation; P(v-a)CO2, venoarterial carbon dioxide tension difference; SaO2, arterial oxygen
saturation; EO2, oxygen extraction percentage.
aP< 0.05 vs. Group I.
bP< 0.05 vs. Group II.
cP< 0.05 vs. Group III.
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the variation in the P(v-a)CO2 and ScvO2
might have been comparable in this large-
sample study. Therefore, our study suggests
that the priority should be paying
close attention to P(v-a)CO2 to correct the
P(v-a)CO2/C(a-v)O2 ratio in critically ill
patients. Further prospective studies are
required to investigate the effects of varia-
tions of other related parameters on the
P(v-a)CO2/C(a-v)O2 ratio.
Behavior of P(v-a)CO2/C(a-v)O2 ratio in
present classification based on ScvO2
and P(v-a)CO2
ScvO2 is a well-known marker that reflects
whether DO2 meets the demand of VO2.
18
Additionally, P(v-a)CO2 functions as a
global flow parameter that reflects whether
the systemic flow meets the needs of tissue
perfusion.19,20 In Group I of the present
study, the combination of low P(v-a)CO2
and low ScvO2 indicated that the global
flow was sufficient but that DO2 did not
meet the demand of VO2. This group had
a significantly lower SaO2 and Hb and
higher EO2 than the other groups. Both
arterial hypoxia and hemodilution could
contribute to low ScvO2 resulting from
insufficient DO2 with a high EO2 and low
P(v-a)CO2 from high compensatory cardiac
output. Interestingly, Group I had the
lowest P(v-a)CO2/C(a-v)O2 ratio (1.00
 0.46) and lowest percentage of a high
P(v-a)CO2/C(a-v)O2 ratio [5.8% (8/136)].
Theoretically, using a low P(v-a)CO2/
C(a-v)O2 ratio to reflect the absence of
anaerobic metabolism should be done with
caution in patients with low ScvO2 together
with low P(v-a)CO2, who have special
hemodilution and arterial blood hypoxemia
conditions with high VO2. A potential path-
ophysiologic mechanism is as follows. First,
the cardiac output shows a compensatory
increase to restore DO2 under conditions
of hypoxemia and/or hemodilution, which
could cause a decrease in the P(v-a)CO2
gap. Second, a low ScvO2 commonly
Figure 5. EO2 in different groups based on the cutoffs of ScvO2 (70%) and P(v-a)CO2 (6 mmHg). *Group I
vs. Groups II, III, and IV; P <0.05. Group IV vs. Groups II and III; P <0.05. EO2, oxygen extraction per-
centage; ScvO2, central venous oxygen saturation; P(v-a)CO2, venoarterial carbon dioxide ten-
sion difference.
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indicates an compensatory increase in the
EO2 because of high oxygen demand.
Third, the P(v-a)CO2 might further
decrease in the presence of low ScvO2
through the Haldane effect.21 Hence, in
Group I of the present study, the
“pseudo-normalization” of the P(v-a)CO2/
C(a-v)O2 ratio might have been related to
high cardiac output together with high
VO2.
22 A recent experimental study also
showed that the P(v-a)CO2/C(a-v)O2 ratio
might be a misleading surrogate for anaer-
obic metabolism in the presence of hemodi-
lution.23 Further clinical studies are
required to validate the meaning of the
P(v-a)CO2/C(a-v)O2 ratio in the Group
I condition.
Group II had high ScvO2 and low P(v-a)
CO2. In this case, both global flow and DO2
appeared to be adequate to meet tissue cell
needs. Sepsis may have been a common
cause of the results seen in Group II, espe-
cially given the hyperdynamic hemodynam-
ic status after early resuscitation. Studies
have supported that normal ScvO2 does
not exclude tissue hypoxia, and even high
ScvO2 has been associated with poor clini-
cal outcomes.24–28 Moreover, 25.9%
(195/751) of the measurements had a high
P(v-a)CO2/C(a-v)O2 ratio in Group II. In
other words, normalization of both ScvO2
and P(v-a)CO2 could not totally exclude the
independence of the presence of anaerobic
metabolism. Here, we stress that a high
P(v-a)CO2/C(a-v)O2 ratio cannot be
simply taken as a marker of increased
DO2 to meet the tissue perfusion needs
under conditions of high ScvO2 and low
P(v-a)CO2. First, oxygen cannot be effec-
tively transported into tissue cells through
the microcirculation when there is a loss of
coherence between the macro- and micro-
circulation.29,30 Second, if a disassociation
exists between cellular oxygen utilization
and tissue perfusion, an increase in DO2
would not help to correct the high P(v-a)
CO2/C(a-v)O2 ratio. Further study is
required to determine whether correction
of the P(v-a)CO2/C(a-v)O2 ratio can
improve tissue perfusion and/or the clinical
outcome when ScvO2 and P(v-a)CO2 have
been normalized.
Group III had a high P(v-a)CO2 of
> 6mmHg and high ScvO2 of 70%, indi-
cating that the global flow might be insuffi-
cient for tissue perfusion, although the DO2
had reached the threshold for the physio-
logic requirements. Eighty-four percent
(176/209) of the measurements had a high
P(v-a)CO2/C(a-v)O2 ratio (>1.68) in Group
III, and a high P(v-a)CO2/C(a-v)O2 ratio
indicates a high possibility of anaerobic
metabolism. A high ScvO2 might result
from dysfunction of the microcirculation
(shunting) and oxygen utilization.26–28
Moreover, an elevated P(v-a)CO2 is not
only dependent on the effect of the global
flow related to tissue hypoxia but is also
dependent on the ability of the microcircu-
latory blood flow to clear the additional
carbon dioxide even during normal/high
global flow. Recent clinical research has
shown that the P(v-a)CO2 gap may also
reflect alterations in the microcirculation
in patients with septic shock.16 Therefore,
we suggest that restoration of the
P(v-a)CO2/C(a-v)O2 ratio should focus on
both global flow and microcirculation flow
in the Group III condition. Some might
argue the lactate level was not higher in
Group III and that lactate is always taken
as a marker of anaerobic metabolism.
However, the agreement between the
P(v-a)CO2/C(a-v)O2 ratio and lactate level
should not be interpreted as representative
of anaerobic metabolism. Studies have
shown the hyperlactatemia is not always
of hypoxic origin in critically ill
patients.31–33
Group IV had a high P(v-a)CO2 of
> 6mmHg and low ScvO2 of< 70%, indi-
cating that both global flow and DO2 were
insufficient for the body’s demand.
Interestingly, only 42% (83/198) of the
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measurements had a high P(v-a)CO2/C(a-v)
O2 ratio in Group IV. In contrast, 58% of
the P(v-a)CO2/C(a-v)O2 ratio measure-
ments were normal (1.68). In other
words, among patients with high P(v-a)
CO2 and low ScvO2, there might be a
more than 50% possibility for the absence
of anaerobic metabolism. Hence, calcula-
tion of the P(v-a)CO2/C(a-v)O2 ratio
might also provide information that would
help to avoid over-resuscitation in patients
with a high P(v-a)CO2 of> 6 mmHg and
low ScvO2 of< 70%. Moreover, low
ScvO2 and high P(v-a)CO2 might result
from a high VO2 condition; in such cases,
both the EO2 and VCO2 are increased. Our
study also showed that Group IV had the
highest EO2. The potential clinical meaning
of the P(v-a)CO2/C(a-v)O2 ratio in the four
groups is summarized in Table 3.
Disassociation of lactate and P(v-a)CO2/
C(a-v)O2 ratio
A significant relationship between lactate
and the P(v-a)CO2/C(a-v)O2 ratio was not
found in the present study. Moreover, there
was no significant difference in the lactate
level between low and high P(v-a)CO2/
C(a-v)O2 ratio measurements. This result
seems to oppose those of published stud-
ies,4–7 and it should be interpreted with cau-
tion. The ability of the P(v-a)CO2/C(a-v)O2
ratio and lactate to reflect anaerobic metab-
olism was not questioned and/or compared
in our study. Several factors could have
confounded the relationship between lac-
tate and the P(v-a)CO2/C(a-v)O2 ratio in
the present study, such as the lactate clear-
ance ability, washout effect, and stress
factors. However, our study supports the
notion that incoherence of lactate and
the P(v-a)CO2/C(a-v)O2 ratio might be
common in critically ill patients. We stress
that attention should be paid to the disas-
sociation of lactate and the P(v-a)CO2/
C(a-v)O2 ratio in clinical practice.
Traditionally, a high lactate level is always
taken as a marker of anaerobic metabolism
and an indicator of the need for resuscita-
tion. This viewpoint has been challenging
because high lactate cannot result from cel-
lular hypoxia in the intensive care unit.
A recent study showed that the P(v-a)
CO2/C(a-v)O2 ratio can provide additional
information on anaerobic metabolism when
compared with the lactate level.9 Further
study is required to validate how to com-
bine lactate and the P(v-a)CO2/C(a-v)O2
ratio to identify cellular hypoxia and
guide resuscitation.
In summary, the P(v-a)CO2/C(a-v)O2
ratio is a potential marker of global
anaerobic metabolism that could provide
additional information regarding the
relationship of global DO2/VO2 when com-
bined with ScvO2 and P(v-a)CO2 in clinical
practice. The above-described findings
could be of interest and should be consid-
ered in the application of the P(v-a)CO2/
C(a-v)O2 ratio in clinical practice.
Limitations
Several limitations of this study should be
acknowledged. First, this was a retrospec-
tive study, and we only focused on the rela-
tionships between relevant parameters and
the P(v-a)CO2/C(a-v)O2 ratio. Validation of
the P(v-a)CO2/C(a-v)O2 ratio as a marker
of cellular hypoxia was not the aim of this
study; therefore, information regarding
prognosis, other tissue perfusion parame-
ters, cellular hypoxia indicators, DO2,
and cardiac output are unavailable.
Importantly, the most significant points of
this study were demonstration of the profile
of the P(v-a)CO2/C(a-v)O2 ratio and identi-
fication of the risk factors contributing to
changes in parameters used in calculation of
the ratio in clinical practice. Second, we
acknowledge that some conclusions in this
study are speculative according to reason-
able pathophysiologic principles. Hence,
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further investigations are required to vali-
date that hemodilution and hypoxemia with
a high VO2 result in pseudo-normalization
of the P(v-a)CO2/C(a-v)O2 ratio. Third, the
P(v-a)CO2/C(a-v)O2 ratio functions as a
parameter to predict the response of an
increase in DO2 according to the concept
of oxygen transport. The DO2 challenge
test is the related method used to evaluate
DO2/VO2 dependence. The limitations of
the global DO2 challenge test must be
taken into consideration; namely, the bal-
ance time of the DO2 challenge and the
mathematical coupling of data when using
the P(v-a)CO2/C(a-v)O2 ratio.
34
Conclusion
The P(v-a)CO2/C(a-v)O2 ratio is always low
in a low ScvO2þ low P(v-a)CO2 condition,
and the P(v-a)CO2/C(a-v)O2 ratio is always
high in a high ScvO2þ low P(v-a)CO2
condition. A high P(v-a)CO2 is the most
relevant factor that contributes to the high
P(v-a)CO2/C(a-v)O2 ratio in critically ill
patients. Before the P(v-a)CO2/C(a-v)O2
ratio is used for shock resuscitation in the clin-
ical setting, further prospective studies are
required to validate the P(v-a)CO2/C(a-v)O2
ratio in different clinical conditions.
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